NovoCure (NVCR) Competitor Comparison
We are evaluating the key criteria listed to compare NovoCure (NVCR) against its competitors in the Medical Instruments & Supplies industry.
Market Capitalization
23 / 44Gross Profits
19 / 40Total Revenue
21 / 43EBITDA
44 / 44Free Cashflow
14 / 44Quick Ratio
5 / 44Earnings per Share
34 / 44Dividend yield
0 / 13Total Cash
7 / 44Performance 3 years
40 / 44Performance 5 years
37 / 44Performance 10 years
29 / 44Linearity 3 years
35 / 44Linearity 5 years
31 / 44Linearity 10 years
2 / 44Total Rank
20 / 44Dividend Rank
31 / 44Valuation Rank
26 / 44Piotroski Rank
23 / 44Muliplier Rank
19 / 44Piotroski Rank - NVCR ranking 23 / 44
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.